Physician profile

Trung H Tran

Interventional Cardiology · Columbia, MO

NPI 1710189592

$8,473.07

in general payments reported to CMS, 2019-2025

39 companies · $339 in 2025

The $339 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,674.61
Education$17.26

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $1,458.55 2019-2024 Amplatzer, Amplatzer Talisman, Jeti Peripheral Catheter
Biotronik INC. $1,044.50 2023-2024 Biomonitor, Rivacor 7 Dr-T, Edora 8 Dr-T
Amgen INC. $895.44 2019-2025 Repatha, Repatha
Novartis Pharmaceuticals Corporation $588.52 2019-2025
Medtronic, INC. $555.75 2021-2025 Onyx Frontier, Symplicity G3, Aurora Ev-Icd Mri Surescan
Janssen Pharmaceuticals, INC $549.97 2019-2024 Xarelto
Edwards Lifesciences Corporation $534.17 2019-2025 Edwards Sapien 3 Ultra Transcatheter Heart Valve
Boston Scientific Corporation $522.71 2019-2024 Rotapro, Watchman Access System, Flextome Cutting Balloon
Astrazeneca Pharmaceuticals LP $298.75 2019-2025 Wainua, Farxiga
Shockwave Medical, INC $249.29 2022-2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Medtronic Vascular, INC. $230.22 2019-2020
Inari Medical, INC. $166.31 2020-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $154.31 2021-2024 Lifevest
Pfizer INC. $143.72 2019-2025
Medtronic Minimed, INC. $137.96 2019
Show all 39 companies
CompanyGeneral paymentsYearsTop products
Philips North America LLC $125.40 2024 (9266) Elca
Bayer Healthcare Pharmaceuticals INC. $79.35 2021-2023
Merck Sharp & Dohme LLC $75.45 2022-2025 Verquvo
Sanofi-Aventis U.S. LLC $69.49 2019-2024
Abiomed $61.00 2023 Impella
Kiniksa Pharmaceuticals International, Plc $58.41 2024 Arcalyst
Livanova USA, INC. $55.40 2021
Amarin Pharma, INC. $50.51 2019-2020
Acist Medical Systems, INC. $49.59 2023
E.R. Squibb & Sons, L.L.C. $34.56 2023-2025 Camzyos, Eliquis
Atricure, INC. $32.24 2023
Biosense Webster, INC. $30.62 2022
Cardiovascular Systems INC. $29.71 2019-2021
Cvrx, INC. $24.98 2025 Barostim Neo System
Cardinal Health 200 LLC $20.59 2021
Kiniksa Pharmaceuticals, LTD. $18.39 2023 Arcalyst
Alnylam Pharmaceuticals INC. $18.16 2025 Amvuttra
Daiichi Sankyo INC. $17.54 2023 Injectafer
Boehringer Ingelheim Pharmaceuticals, INC. $17.47 2023 Jardiance
Novo Nordisk INC $16.05 2025 Rybelsus, Ozempic
Teleflex LLC $15.64 2023 Guideliner
Genentech USA, INC. $15.37 2021
Bardy Diagnostics, INC. $15.00 2021
Chiesi USA, INC. $11.98 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Trung H Tran

$8,473.07

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $339 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/349750/trung-h-tran

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.